The rise in prevalence of autoantibodies neutralizing type I interferons reaches a plateau in centenarians
Authors:
- Nanna MørkNMNanna Mørk
- Julie A. JensenJJJulie A. Jensen
- Paul BastardPBPaul Bastard
- Lisbeth Aagaard LarsenLLLisbeth Aagaard Larsen
- Bettina BundgaardBBBettina Bundgaard
- Marianne NygaardMNMarianne Nygaard
- Signe Bedsted ClemmensenSCSigne Bedsted Clemmensen
- Chiaki TaoCTChiaki Tao
- Vibeke Sorensen CattsVCVibeke Sorensen Catts
- Anne PuelAPAnne Puel
- Guillaume VogtGVGuillaume Vogt
- Ivan David Lozada-MartinezILIvan David Lozada-Martinez
Open Access
- 27 October 2026
- journal article
- Published by Rockefeller University Press in Journal of Human Immunity
- Vol. 3 (1)
Abstract
While autoantibodies (auto-Abs) neutralizing type I interferons (IFN-I) are relatively rare before the age of 65 (6% in individuals above 80 years in the general population. To assess the prevalence of IFN-I auto-Abs at the extreme end of human lifespan, we performed a multinational study of centenarians from four geographically and ethnically distinct cohorts collected in Denmark (n = 258), Colombia (n = 99), Australia (n = 281), and Japan (n = 300), comprising 938 individuals. Across cohorts, 51/938 centenarians (5.4%) harbored auto-Abs neutralizing IFN-I, ranging from 3.3% (Japan) to 9.1% (Colombia). We found that the prevalence of IFN-I auto-Abs levels off in centenarians compared with individuals ≥80 years from the general population, demonstrating that neutralizing IFN-I auto-Abs are not incompatible with longevity, despite conferring a risk of life-threatening viral infections. Yet, the plateau of their prevalence in centenarians suggests that they may not be beneficial for reaching exceptional longevity and may negatively impact mortality.Keywords
This publication has 48 references indexed in Scilit:
- Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infectionsCell, 2026
- Immunosenescence and human healthspan. Lessons from centenariansCurrent Opinion in Immunology, 2026
- Mosaic loss of Y chromosome and the association to mortality in Danish men aged 56–100 yearsMechanisms of Ageing and Development, 2024
- Autoimmunity in centenarians. A paradoxJournal of Translational Autoimmunity, 2024
- Hallmarks of aging: An expanding universeCell, 2023
- Neutralizing Type I Interferon Autoantibodies in Japanese Patients with Severe COVID-19Journal of Clinical Immunology, 2022
- Autoantibodies Neutralizing Type I Interferons in 20% of COVID-19 Deaths in a French HospitalJournal of Clinical Immunology, 2022
- AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating AutoantibodiesCell, 2016
- The Sydney Centenarian Study: methodology and profile of centenarians and near-centenariansInternational Psychogeriatrics, 2013
- PATIENT WITH CIRCULATING ANTIBODIES TO α-INTERFERONThe Lancet, 1981